Loading...
Combatting the Opioid Crisis: The Price Increase of an Opioid Overdose Reversal Drug and the Cost to the U.S. Healthcare System
Senate Committee on Homeland Security and Governmental Affairs Permanent Subcommittee on Investigations
Senate Committee on Homeland Security and Governmental Affairs
Permanent Subcommittee on Investigations
Abstract
The Homeland Security and Governmental Affairs' Permanent Subcommittee on Investigations conducted several investigations on the opioid epidemic and the Federal Government's response. Specifically, the Subcommittee investigated the cost of naloxone and how a single pharmaceutical company exploited the opioid crisis by increasing the price of the drug. It was discovered that the company increased the price of naloxone by 600 percent, resulting in more than $142 million in charges to taxpayers.
Date
2018-11-18
Document Type
Senate Bipartisan Staff Report
Serial Number
Document Length
99 pages
Congress
115
Relation
DOI
Keywords
Staff Reports, Bipartisan
PAP Major Code
3: Health
PAP Minor Code
342: Substance, Alcohol and Drug Abuse, Treatment and Education